Search
CRISPR Therapeutics AG
CRSPAdd to Watchlist
48.405USD
-3.370-6.51%
Market hours 11/05, 13:37（ET）
4.68BMarket Cap
LossP/E TTM
CRSP Financials
See CRISPR Therapeutics AG's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
4.68B
Dividend TTM
0.00
P/E TTM
-7.85
EPS TTM
-6.16
Revenue
3.51M
Net Profit
-366.25M
ROE
-31.21%
ROA
-23.24%
CRISPR Therapeutics AG Earnings Date
Latest Release
Nov 2, 2026
EPS / Forecast
-1.15/-1.04
Revenue / Forecast
12.67M/10.49M
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its total revenue reached 3.51M, with a year-on-year change of 37.31M.
What are the current assets of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its current assets were 1.99B, with a year-on-year change of 2.51.
What are the total assets of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its total assets of CRISPR Therapeutics AG were 2.27B, with a year-on-year change of 1.04.
What are the total liabilities of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its total liabilities of CRISPR Therapeutics AG were 343.43M, with a year-on-year change of 10.80.
What is the total equity of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its total equity of CRISPR Therapeutics AG was 1.92B, with a year-on-year change of -0.53.
What is the net operating income of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its net operating income of CRISPR Therapeutics AG was -568.32M, with a year-on-year change of -21.81.
What is the net investment of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its net investment of CRISPR Therapeutics AG was -31.80M, with a year-on-year change of 88.66.
What is the net financing of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its net financing of CRISPR Therapeutics AG was 426.03M, with a year-on-year change of 28.33.
What is the Earnings Per Share (EPS) of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its Earnings Per Share (EPS) was -6.47, with a year-on-year change of -48.97.
What is the net income of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its net income was -581.60M, with a year-on-year change of -58.80.
What is the net margin of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its net profit margin was -16569.77, with a year-on-year change of -1588.14.
What is the Return on Equity (ROE) of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its Return on Equity (ROE) was -30.18, with a year-on-year change of -57.19.
What is the Return on Assets (ROA) of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its Return on Assets (ROA) was -25.81, with a year-on-year change of -57.54.
What is the operating profit of CRISPR Therapeutics AG?
According to CRISPR Therapeutics AG's FY2025 earnings report, its operating profit was -568.32M, with a year-on-year change of -21.81.